𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Specificity of TP53 mutation screening methods in cancerous tissues

✍ Scribed by Jean Breton; Mathilde Lechevrel; François Sichel

Publisher
John Wiley and Sons
Year
2005
Tongue
French
Weight
87 KB
Volume
118
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TP53 gene mutations in plasma DNA of can
TP53 gene mutations in plasma DNA of cancer patients
✍ Jose M. Silva; Rocio Gonzalez; Gemma Dominguez; Jose M. Garcia; Pilar España; Fe 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

Using different molecular techniques, DNA has been shown to be present in plasma of patients with several types of tumors. Mutations of TP53 are the most common genetic changes in human cancers. We investigated the presence of TP53 gene mutations in plasma DNA of breast and small cell lung cancer pa

DHPLC is superior to SSCP in screening p
DHPLC is superior to SSCP in screening p53 mutations in esophageal cancer tissues
✍ Osamu Yamanoshita; Takeo Kubota; Jun Hou; Yu-Min Ping; Xiu-Lan Zhang; Xiang-Ping 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 109 KB

Mutations of the p53 tumor-suppressor gene universally occur on exons 5-8 in human cancer. We analyzed these mutations in esophageal cancer tissue from 207 patients in China using 2 methods, single-strand conformation polymorphism (SSCP), one of the most frequently used methods, and the recently dev

MUT-TP53 2.0: a novel versatile matrix f
MUT-TP53 2.0: a novel versatile matrix for statistical analysis of TP53 mutations in human cancer
✍ Thierry Soussi; Dalil Hamroun; Linn Hjortsberg; Jean Michel Rubio-Nevado; Jean L 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

Analysis of the literature reporting p53 mutations shows that 8% of report display typographical mistakes with a notable increase in recent years. These errors are sometimes isolated, but in some cases, they concern several or even all mutations described in a single article. Furthermore, some works

Significance of TP53 mutations in human
Significance of TP53 mutations in human cancer: A critical analysis of mutations at CpG dinucleotides
✍ Thierry Soussi; Christophe Béroud 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 1 views

A detailed analysis of p53 (TP53) mutations involving the 42 CpG dinucleotides was performed to gain greater insight into the mutational mechanism leading to specific selection of these mutations. Although the majority of these CpG dinucleotides have been found to be mutated in cancer cells, the het

TP53 in hematological cancer: Low incide
TP53 in hematological cancer: Low incidence of mutations with significant clinical relevance
✍ Shoshana Peller; Varda Rotter 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views

Inactivation of the wild-type p53 gene (TP53) by various genetic alterations is a major event in human tumorigenesis. More than 60% of human primary tumors exhibit a mutation in the p53 gene. Hematological malignancies present a rather low incidence of genetic alterations in this gene (10-20%). Neve